glp-1 pancreatitis risk Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response GLP-1 Agonist Side Effects: Pancreatitis

Most state Medicaid programs dont cover the new class of weight loss drugs for obesity, but that could soon change

For many people, that tradeoff is worth it given the access and cost difference

Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake

What makes GLP-1 drugs particularly intriguing is that they appear to work through a mechanism distinct from traditional addiction treatments

J., Patel, P., et al

Zepbound: Representing the next evolution in treatment, Zepbound has shown even greater promise in clinical trials, offering patients in search of Detroit weight loss a new level of efficacy